Electrophysiological characterisation in hereditary spastic paraplegia type 5

Clinical Neurophysiology

Volumn 122, Issue 4, 2011, Pages 819-822

  Manganelli, Fiore ^a   Pisciotta, Chiara ^a   Dubbioso, Raffaele ^a   Iodice, Rosa ^a   Criscuolo, Chiara ^a   Ruggiero, Lucia ^a   Michele, Giuseppe De ^a   Santoro, Lucio ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Axonopathy; Demyelination; Hereditary spastic paraplegia; Multimodal evoked potentials; SPG5

Indexed keywords

ADULT; ARTICLE; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; ELECTROMYOGRAPHY; ELECTROPHYSIOLOGY; EVOKED AUDITORY RESPONSE; EVOKED MUSCLE RESPONSE; EVOKED SOMATOSENSORY RESPONSE; EVOKED VISUAL RESPONSE; FEMALE; HUMAN; MALE; MOLECULAR DIAGNOSIS; MOTOR NERVE CONDUCTION; NERVE CONDUCTION; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; SPASTIC PARAPLEGIA; SPASTIC PARAPLEGIA 5; TRANSCRANIAL MAGNETIC STIMULATION;

ADULT; AGE OF ONSET; CENTRAL NERVOUS SYSTEM; CHILD; ELECTROMYOGRAPHY; ELECTROPHYSIOLOGICAL PHENOMENA; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; EVOKED POTENTIALS, MOTOR; EVOKED POTENTIALS, SOMATOSENSORY; EVOKED POTENTIALS, VISUAL; FEMALE; FUNCTIONAL LATERALITY; HUMANS; MALE; MEDIAN NERVE; MIDDLE AGED; MOTOR NEURONS; MUSCLE, SKELETAL; NEURAL CONDUCTION; PERIPHERAL NERVOUS SYSTEM; SPASTIC PARAPLEGIA, HEREDITARY;

EID: 79952315361     PISSN: 13882457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinph.2010.10.025     Document Type: Article

References (17)

1. Criscuolo C., Filla A., Coppola G., Rinaldi C., Carbone R., Pinto S., et al. Two novel CYP7B1 mutations in Italian families with SPG5: a clinical and genetic study. J. Neurol. 2009, 256:1252-1257.
2. De Stefano N., Dotti M.T., Mortilla M., Federico A. Magnetic resonance imaging and spectroscopic changes in brains of patients with cerebrotendinous xanthomatosis. Brain 2001, 124:121-131.
3. Recommendations for the practice of clinical neurophysiology. IFCN Guidelines. Electroencephalogr. Clin. Neurophysiol. 1999, (Suppl. 52).
4. Espinós C., Palau F. Genetics and pathogenesis of inherited ataxias and spastic paraplegias. Adv. Exp. Med. Biol. 2009, 652:263-296.
5. Goizet C., Boukhris A., Durr A., Beetz C., Truchetto J., Tesson C., et al. CYP7B1 mutations in pure and complex forms of hereditary spastic paraplegia type 5. Brain 2009, 132:1589-1600.
6. Klebe S., Durr A., Bouslam N., Grid D., Paternotte C., Depienne C., et al. Spastic paraplegia 5: locus refinement, candidate gene analysis and clinical description. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2007, 144B:854-861.
7. Mondelli M., Rossi A., Scarpini C., Dotti M.T., Federico A. Evoked potentials in cerebrotendinous xanthomatosis and effect induced by chenodeoxycholic acid. Arch. Neurol. 1992, 49:469-475.
8. Mondelli M., Sicurelli F., Scarpini C., Dotti M.T., Federico A. Cerebrotendinous xanthomatosis: 11-year treatment with chenodeoxycholic acid in five patients. An electrophysiological study. J. Neurol. Sci. 2001, 190:29-33.
9. Philippart M., Van Bogaert L. Cholestanolosis (cerebrotendinous xanthomatosis). A follow-up study on the original family. Arch. Neurol. 1969, 21:603-610.
10. Pilo de la Fuente B., Ruiz I., Lopez de Munain A., Jimenez-Escrig A. Cerebrotendinous xanthomatosis: neuropathological findings. J. Neurol. 2008, 255:839-842.
11. Pop P.H., Joosten E., van Spreeken A., Gabreëls-Festen A., Jaspar H., ter Laak H., et al. Neuroaxonal pathology of central and peripheral nervous systems in cerebrotendinous xanthomatosis (CTX). Acta Neuropathol. 1984, 64:259-264.
12. Restuccia D., Di Lazzaro V., Servidei S., Colosimo C., Tonali P. Somatosensory and motor evoked potentials in the assessment of cerebrotendinous xanthomatosis before and after treatment with chenodeoxycholic acid: a preliminary study. J. Neurol. Sci. 1992, 112:139-146.
13. Schüle R., Brandt E., Karle K.N., Tsaousidou M., Klebe S., Klimpe S., et al. Analysis of CYP7B1 in non-consanguineous cases of hereditary spastic paraplegia. Neurogenetics 2009, 10:97-104.
14. Soffer D., Benharroch D., Berginer V. The neuropathology of cerebrotendinous xanthomatosis revisited: a case report and review of the literature. Acta Neuropathol. 1995, 90:213-220.
15. Tokimura Y., Kuriyama M., Arimura K., Fujiyama J., Osame M. Electrophysiological studies in cerebrotendinous xanthomatosis. J. Neurol. Neurosurg. Psychiatry. 1992, 55:52-55.
16. Tsaousidou M.K., Ouahchi K., Warner T.T., Yang Y., Simpson M.A., Laing N.G., et al. Sequence alterations within CYP7B1 implicate defective cholesterol homeostasis in motor-neuron degeneration. Am. J. Hum. Genet. 2008, 82:510-515.
17. Wilkinson P.A., Crosby A.H., Turner C., Patel H., Wood N.W., Schapira A.H., et al. A clinical and genetic study of SPG5A linked autosomal recessive hereditary spastic paraplegia. Neurology 2003, 61:235-238.